Neurology

Single-dose MM120 provides fast, lasting anxiety relief in generalised anxiety disorder, paving the way for new treatments.

Frequent use of artificial sweeteners may speed up memory loss and thinking decline, particularly for those with diabetes.

AI speech analysis detects neurological disorders with over 90 percent accuracy, promising rapid non-invasive screening worldwide.

A large cohort study using data from the UK Biobank has found that metabolic syndrome is associated with an increased risk of developing Parkinson’s disease, particularly in individuals with a high genetic predisposition.

Medical cannabis linked to better sleep, mood, and life quality in insomnia patients over 18 months, real-world study finds.

Focal epilepsy study shows most patients need over a year and multiple medications to gain seizure control.

Prenatal pesticide exposure linked to brain abnormalities and motor deficits in children, new MRI study shows.

Over half of chronic pain patients discontinue medical cannabis within a year, highlighting need for individualised care.